Streetbeat News

Price Targets

CBAY

Piper Sandler analyst Yasmeen Rahimi maintains an Overweight rating on CymaBay Therapeutics (NASDAQ:CBAY) and raises the price target from $19 to $33.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:26 pm

MLTX

Wedbush analyst Andreas Argyrides has reiterated an Outperform rating on MoonLake (NASDAQ:MLTX) and maintained a price target of $86.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:25 pm

ZTS

Piper Sandler analyst David Westenberg maintains an Overweight rating on Zoetis (NYSE:ZTS) and raises the price target from $210 to $215.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:24 pm

ELEV

Wedbush analyst Robert Driscoll has reiterated an Outperform rating on Elevation Oncology (NASDAQ:ELEV) and maintained a $5 price target.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:20 pm

IDXX

Piper Sandler analyst David Westenberg maintains an Overweight rating on IDEXX Laboratories (NASDAQ:IDXX) and raises the price target from $520 to $525.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:19 pm

HR

Wedbush analyst Richard Anderson has reiterated an Outperform rating on Healthcare Realty Trust (NYSE:HR) and maintained a $17 price target.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:18 pm

PACB

Piper Sandler analyst David Westenberg has maintained a Neutral rating on Pacific Biosciences (NASDAQ:PACB) and lowered the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:16 pm

DGX

Piper Sandler analyst David Westenberg maintains a Neutral rating on Quest Diagnostics (NYSE:DGX) and raises the price target from $130 to $140.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:14 pm

BIRK

Deutsche Bank analyst Gabriella Carbone initiates coverage on Birkenstock Holding (NYSE:BIRK) with a Hold rating and announces a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 3:11 pm

CFLT

RBC Capital analyst Matthew Hedberg has initiated coverage on Confluent (NASDAQ:CFLT) with an Outperform rating and a price target of $22.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 2:34 pm